These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23027454)

  • 61. Sex difference in risk of torsade de pointes with d,l-sotalol.
    Lehmann MH; Hardy S; Archibald D; quart B; MacNeil DJ
    Circulation; 1996 Nov; 94(10):2535-41. PubMed ID: 8921798
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effects of hormones on arrhythmias in women.
    Bailey MS; Curtis AB
    Curr Womens Health Rep; 2002 Apr; 2(2):83-8. PubMed ID: 12116606
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 64. QT prolongation and arrhythmia suppression.
    Roden DM; Woosley RL
    Am Heart J; 1985 Feb; 109(2):411-5. PubMed ID: 2578242
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide.
    Pedersen HS; Elming H; Seibaek M; Burchardt H; Brendorp B; Torp-Pedersen C; Køber L;
    Am J Cardiol; 2007 Sep; 100(5):876-80. PubMed ID: 17719337
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.
    De Ponti F; Poluzzi E; Cavalli A; Recanatini M; Montanaro N
    Drug Saf; 2002; 25(4):263-86. PubMed ID: 11994029
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiarrhythmic effects of magnesium sulphate. Report of three cases.
    Knudsen K; Abrahamsson J
    Acta Anaesthesiol Scand; 1995 Aug; 39(6):850-4. PubMed ID: 7484048
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Amiodarone and torsade de pointes.
    Lazzara R
    Ann Intern Med; 1989 Oct; 111(7):549-51. PubMed ID: 2672929
    [No Abstract]   [Full Text] [Related]  

  • 72. Acquired long QT syndrome in chronic kidney disease patients.
    Liu P; Wang L; Han D; Sun C; Xue X; Li G
    Ren Fail; 2020 Nov; 42(1):54-65. PubMed ID: 31878817
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A benefit-risk assessment of class III antiarrhythmic agents.
    Brendorp B; Pedersen O; Torp-Pedersen C; Sahebzadah N; Køber L
    Drug Saf; 2002; 25(12):847-65. PubMed ID: 12241126
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanisms and management of proarrhythmia.
    Roden DM
    Am J Cardiol; 1998 Aug; 82(4A):49I-57I. PubMed ID: 9737654
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risks and benefits of antiarrhythmic therapy.
    Roden DM
    N Engl J Med; 1994 Sep; 331(12):785-91. PubMed ID: 8065408
    [No Abstract]   [Full Text] [Related]  

  • 76. Inhibition of Late Sodium Current as an Innovative Antiarrhythmic Strategy.
    Bengel P; Ahmad S; Sossalla S
    Curr Heart Fail Rep; 2017 Jun; 14(3):179-186. PubMed ID: 28455610
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of ventricular pacing in the treatment of an arrhythmic storm associated with a congenital long QT mutation.
    Aziz PF; Shah MJ
    Congenit Heart Dis; 2013; 8(6):E165-7. PubMed ID: 23075154
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application.
    Tadros R; Cadrin-Tourigny J; Abadir S; Rivard L; Nattel S; Talajic M; Khairy P
    Expert Rev Cardiovasc Ther; 2015; 13(7):769-82. PubMed ID: 25994014
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Drug-induced long QT syndrome in women: review of current evidence and remaining gaps.
    Hreiche R; Morissette P; Turgeon J
    Gend Med; 2008 Jun; 5(2):124-35. PubMed ID: 18573480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.